US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 6.280
  • -0.190-2.94%
Close May 17 16:00 ET
  • 6.250
  • -0.030-0.48%
Post 19:55 ET
1.30BMarket Cap-5869P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
38.93%-47.51M
-13.85%-161.85M
26.53%-23.85M
-39.39%-32.44M
-9.23%-27.76M
Net income from continuing operations
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
Operating gains losses
----
--29.02M
--0
--0
----
----
----
----
----
----
Depreciation and amortization
-24.44%306K
15.17%1.66M
6.82%423K
7.97%420K
21.49%407K
27.76%405K
84.94%1.44M
131.58%396K
69.87%389K
68.34%335K
Other non cash items
-4.95%19.44M
-13.65%86.23M
-55.42%19.94M
20.22%22.11M
33.85%23.72M
7.63%20.45M
84.21%99.85M
151.81%44.73M
33.52%18.39M
52.29%17.72M
Change In working capital
-75.44%-48.52M
45.03%-32.4M
253.94%18.1M
9.64%-16.2M
-301.58%-6.64M
15.04%-27.66M
-825.57%-58.95M
-179.66%-11.76M
-311.17%-17.93M
293.77%3.3M
-Change in receivables
-290.14%-3.84M
71.61%-6.1M
61.14%-2.97M
358.96%3.84M
-69.73%-8.99M
128.65%2.02M
-3.14%-21.47M
-136.04%-7.64M
-206.23%-1.48M
71.71%-5.3M
-Change in inventory
-1,031.30%-1.22M
88.33%-1.45M
178.19%907K
7.84%-3.39M
112.41%898K
137.01%131K
-41.70%-12.42M
45.72%-1.16M
3.85%-3.67M
-52.77%-7.24M
-Change in prepaid assets
143.42%1.11M
-164.03%-6.82M
148.93%710K
-7,273.17%-6.05M
-16.30%1.06M
-9.78%-2.55M
63.90%-2.58M
60.73%-1.45M
97.61%-82K
-87.06%1.27M
-Change in payables and accrued expense
-63.70%-44.57M
24.84%-16.81M
1,964.17%19.87M
27.80%-9.26M
-101.30%-188K
-18.85%-27.23M
-151.31%-22.36M
-104.63%-1.07M
-189.82%-12.83M
22.56%14.45M
-Change in other working capital
----
-1,028.44%-1.23M
4.34%-419K
-1,041.26%-1.35M
413.51%570K
-146.67%-35K
-108.50%-109K
-153.03%-438K
164.81%143K
-25.00%111K
Cash from discontinued investing activities
Operating cash flow
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
38.93%-47.51M
-13.85%-161.85M
26.53%-23.85M
-39.39%-32.44M
-9.23%-27.76M
Investing cash flow
Cash flow from continuing investing activities
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
-911.43%-128.24M
794.38%77.22M
-997.68%-69.54M
-2,263.37%-97.44M
Net PPE purchase and sale
-46.88%-235K
-60.47%-2.17M
-5.32%-554K
-464.00%-987K
-91.39%-467K
60.59%-160K
43.35%-1.35M
52.53%-526K
52.05%-175K
69.99%-244K
Net investment purchase and sale
127.11%28.99M
-1.93%-129.33M
-135.91%-27.92M
134.75%24.11M
80.90%-18.57M
-180.96%-106.95M
-797.60%-126.89M
876.48%77.74M
-955.13%-69.37M
-1,927.99%-97.19M
Cash from discontinued investing activities
Investing cash flow
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
-911.43%-128.24M
794.38%77.22M
-997.68%-69.54M
-2,263.37%-97.44M
Financing cash flow
Cash flow from continuing financing activities
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
-30.98%5.08M
-75.53%88.03M
-98.79%4.2M
1,498.09%76.33M
-96.79%147K
Net issuance payments of debt
---390K
-20.10%58.38M
---1.17M
--0
--59.55M
--0
-75.13%73.07M
--0
--73.07M
----
Net common stock issuance
--11K
80.00%342K
----
----
----
--0
-99.62%190K
----
----
----
Proceeds from stock option exercised by employees
-66.89%1.68M
-43.52%8.34M
-104.44%-178K
-54.29%1.49M
1,229.25%1.95M
-30.98%5.08M
-6.16%14.77M
15.07%4.01M
-31.89%3.25M
-96.79%147K
Net other financing activities
---2.35M
---34.58M
---2.17M
---262K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
-30.98%5.08M
-75.53%88.03M
-98.79%4.2M
1,498.09%76.33M
-96.79%147K
Net cash flow
Beginning cash position
-63.28%112.45M
-39.69%306.24M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
-39.69%306.24M
85.07%507.73M
21.80%248.34M
27.65%274.02M
72.73%398.86M
Current changes in cash
82.63%-25.98M
3.91%-194.15M
-170.47%-40.56M
117.33%4.45M
93.21%-8.49M
-37.30%-149.54M
-186.60%-202.06M
-81.05%57.57M
-138.65%-25.66M
-665.62%-125.05M
Effect of exchange rate changes
-254.17%-340K
-36.04%362K
57.70%522K
1,907.14%253K
-251.67%-317K
-340.00%-96K
697.18%566K
16,450.00%331K
12.50%-14K
145.88%209K
End cash Position
-45.00%86.13M
-63.28%112.45M
-63.28%112.45M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
-39.69%306.24M
-39.69%306.24M
21.80%248.34M
27.65%274.02M
Free cash flow
-13.10%-53.92M
40.37%-97.31M
61.14%-9.47M
35.98%-20.88M
31.14%-19.28M
39.04%-47.67M
-12.91%-163.2M
27.38%-24.38M
-37.98%-32.62M
-6.78%-28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M38.93%-47.51M-13.85%-161.85M26.53%-23.85M-39.39%-32.44M-9.23%-27.76M
Net income from continuing operations 33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M-36.25%-58.86M
Operating gains losses ------29.02M--0--0------------------------
Depreciation and amortization -24.44%306K15.17%1.66M6.82%423K7.97%420K21.49%407K27.76%405K84.94%1.44M131.58%396K69.87%389K68.34%335K
Other non cash items -4.95%19.44M-13.65%86.23M-55.42%19.94M20.22%22.11M33.85%23.72M7.63%20.45M84.21%99.85M151.81%44.73M33.52%18.39M52.29%17.72M
Change In working capital -75.44%-48.52M45.03%-32.4M253.94%18.1M9.64%-16.2M-301.58%-6.64M15.04%-27.66M-825.57%-58.95M-179.66%-11.76M-311.17%-17.93M293.77%3.3M
-Change in receivables -290.14%-3.84M71.61%-6.1M61.14%-2.97M358.96%3.84M-69.73%-8.99M128.65%2.02M-3.14%-21.47M-136.04%-7.64M-206.23%-1.48M71.71%-5.3M
-Change in inventory -1,031.30%-1.22M88.33%-1.45M178.19%907K7.84%-3.39M112.41%898K137.01%131K-41.70%-12.42M45.72%-1.16M3.85%-3.67M-52.77%-7.24M
-Change in prepaid assets 143.42%1.11M-164.03%-6.82M148.93%710K-7,273.17%-6.05M-16.30%1.06M-9.78%-2.55M63.90%-2.58M60.73%-1.45M97.61%-82K-87.06%1.27M
-Change in payables and accrued expense -63.70%-44.57M24.84%-16.81M1,964.17%19.87M27.80%-9.26M-101.30%-188K-18.85%-27.23M-151.31%-22.36M-104.63%-1.07M-189.82%-12.83M22.56%14.45M
-Change in other working capital -----1,028.44%-1.23M4.34%-419K-1,041.26%-1.35M413.51%570K-146.67%-35K-108.50%-109K-153.03%-438K164.81%143K-25.00%111K
Cash from discontinued investing activities
Operating cash flow -12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M38.93%-47.51M-13.85%-161.85M26.53%-23.85M-39.39%-32.44M-9.23%-27.76M
Investing cash flow
Cash flow from continuing investing activities 126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M-178.41%-107.11M-911.43%-128.24M794.38%77.22M-997.68%-69.54M-2,263.37%-97.44M
Net PPE purchase and sale -46.88%-235K-60.47%-2.17M-5.32%-554K-464.00%-987K-91.39%-467K60.59%-160K43.35%-1.35M52.53%-526K52.05%-175K69.99%-244K
Net investment purchase and sale 127.11%28.99M-1.93%-129.33M-135.91%-27.92M134.75%24.11M80.90%-18.57M-180.96%-106.95M-797.60%-126.89M876.48%77.74M-955.13%-69.37M-1,927.99%-97.19M
Cash from discontinued investing activities
Investing cash flow 126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M-178.41%-107.11M-911.43%-128.24M794.38%77.22M-997.68%-69.54M-2,263.37%-97.44M
Financing cash flow
Cash flow from continuing financing activities -120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M-30.98%5.08M-75.53%88.03M-98.79%4.2M1,498.09%76.33M-96.79%147K
Net issuance payments of debt ---390K-20.10%58.38M---1.17M--0--59.55M--0-75.13%73.07M--0--73.07M----
Net common stock issuance --11K80.00%342K--------------0-99.62%190K------------
Proceeds from stock option exercised by employees -66.89%1.68M-43.52%8.34M-104.44%-178K-54.29%1.49M1,229.25%1.95M-30.98%5.08M-6.16%14.77M15.07%4.01M-31.89%3.25M-96.79%147K
Net other financing activities ---2.35M---34.58M---2.17M---262K------------------------
Cash from discontinued financing activities
Financing cash flow -120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M-30.98%5.08M-75.53%88.03M-98.79%4.2M1,498.09%76.33M-96.79%147K
Net cash flow
Beginning cash position -63.28%112.45M-39.69%306.24M-38.60%152.49M-46.07%147.79M-60.74%156.6M-39.69%306.24M85.07%507.73M21.80%248.34M27.65%274.02M72.73%398.86M
Current changes in cash 82.63%-25.98M3.91%-194.15M-170.47%-40.56M117.33%4.45M93.21%-8.49M-37.30%-149.54M-186.60%-202.06M-81.05%57.57M-138.65%-25.66M-665.62%-125.05M
Effect of exchange rate changes -254.17%-340K-36.04%362K57.70%522K1,907.14%253K-251.67%-317K-340.00%-96K697.18%566K16,450.00%331K12.50%-14K145.88%209K
End cash Position -45.00%86.13M-63.28%112.45M-63.28%112.45M-38.60%152.49M-46.07%147.79M-60.74%156.6M-39.69%306.24M-39.69%306.24M21.80%248.34M27.65%274.02M
Free cash flow -13.10%-53.92M40.37%-97.31M61.14%-9.47M35.98%-20.88M31.14%-19.28M39.04%-47.67M-12.91%-163.2M27.38%-24.38M-37.98%-32.62M-6.78%-28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg